BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 35296306)

  • 1. Evaluating the variety of GNAS inactivation disorders and their clinical manifestations in 11 Chinese children.
    Chang G; Li Q; Li N; Li G; Li J; Ding Y; Huang X; Shen Y; Wang J; Wang X
    BMC Endocr Disord; 2022 Mar; 22(1):70. PubMed ID: 35296306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and Molecular Characteristics of GNAS Inactivation Disorders Observed in 18 Korean Patients.
    Han SR; Lee YA; Shin CH; Yang SW; Lim BC; Cho TJ; Ko JM
    Exp Clin Endocrinol Diabetes; 2021 Feb; 129(2):118-125. PubMed ID: 31546270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for GNAS genetic and epigenetic alterations in progressive osseous heteroplasia: first Italian series.
    Elli FM; Barbieri AM; Bordogna P; Ferrari P; Bufo R; Ferrante E; Giardino E; Beck-Peccoz P; Spada A; Mantovani G
    Bone; 2013 Oct; 56(2):276-80. PubMed ID: 23796510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and mutational spectrum of progressive osseous heteroplasia (POH) and other forms of GNAS-based heterotopic ossification.
    Adegbite NS; Xu M; Kaplan FS; Shore EM; Pignolo RJ
    Am J Med Genet A; 2008 Jul; 146A(14):1788-96. PubMed ID: 18553568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GNAS mutations in Pseudohypoparathyroidism type 1a and related disorders.
    Lemos MC; Thakker RV
    Hum Mutat; 2015 Jan; 36(1):11-9. PubMed ID: 25219572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive osseous heteroplasia, as an isolated entity or overlapping with Albright hereditary osteodystrophy.
    Lin MH; Numbenjapon N; Germain-Lee EL; Pitukcheewanont P
    J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):911-8. PubMed ID: 25894639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild progressive osseous heteroplasia overlap syndrome with PTH and TSH resistance appearing during adolescence and not early childhood.
    Ozaki K; Mituboshi A; Nagai M; Nishiyama A; Nishimura G; Morisada N; Iijima K
    Endocrine; 2021 Dec; 74(3):685-689. PubMed ID: 34254228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Paternal GNAS mutations: Which phenotypes? What genetic counseling?].
    Kottler ML
    Ann Endocrinol (Paris); 2015 May; 76(2):105-9. PubMed ID: 25952723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characterization and identification of two novel mutations of the GNAS gene in patients with pseudohypoparathyroidism and pseudopseudohypoparathyroidism.
    Jin HY; Lee BH; Choi JH; Kim GH; Kim JK; Lee JH; Yu J; Yoo JH; Ko CW; Lim HH; Chung HR; Yoo HW
    Clin Endocrinol (Oxf); 2011 Aug; 75(2):207-13. PubMed ID: 21521295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive osseous heteroplasia in a Chinese infant and a novel mutation in the GNAS gene.
    Zhang SD; Xie ZL; Zhang KQ; Nh-Tseung K; Zhao JJ
    J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):e209-e211. PubMed ID: 29224258
    [No Abstract]   [Full Text] [Related]  

  • 11. GNAS gene mutations affecting XLαs and bone health: A long neglected relationship.
    Xie Y; Chen X; Xie Y; Yu X
    Clin Genet; 2023 Sep; 104(3):279-286. PubMed ID: 37249323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudohypoparathyroidism type Ia and pseudo-pseudohypoparathyroidism: the growing spectrum of GNAS inactivating mutations.
    Elli FM; deSanctis L; Ceoloni B; Barbieri AM; Bordogna P; Beck-Peccoz P; Spada A; Mantovani G
    Hum Mutat; 2013 Mar; 34(3):411-6. PubMed ID: 23281139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive osseous heteroplasia is not a Mendelian trait but a type 2 segmental manifestation of GNAS inactivation disorders: A hypothesis.
    Happle R
    Eur J Med Genet; 2016 May; 59(5):290-4. PubMed ID: 27058263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and genetic characteristics of Pseudohypoparathyroidism in the Chinese population.
    Chu X; Zhu Y; Wang O; Nie M; Quan T; Xue Y; Wang W; Jiang Y; Li M; Xia W; Xing X
    Clin Endocrinol (Oxf); 2018 Feb; 88(2):285-294. PubMed ID: 29136292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Definition of Pseudohypoparathyroidism Variants.
    Jüppner H
    J Clin Endocrinol Metab; 2021 May; 106(6):1541-1552. PubMed ID: 33529330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive osseous heteroplasia-like heterotopic ossification in a male infant with pseudohypoparathyroidism type Ia: a case report.
    Gelfand IM; Hub RS; Shore EM; Kaplan FS; Dimeglio LA
    Bone; 2007 May; 40(5):1425-8. PubMed ID: 17321228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation defect in imprinted genes detected in patients with an Albright's hereditary osteodystrophy like phenotype and platelet Gs hypofunction.
    Izzi B; Francois I; Labarque V; Thys C; Wittevrongel C; Devriendt K; Legius E; Van den Bruel A; D'Hooghe M; Lambrechts D; de Zegher F; Van Geet C; Freson K
    PLoS One; 2012; 7(6):e38579. PubMed ID: 22679513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medulloblastoma in a child with osteoma cutis - a rare association due to loss of
    Suntharesan J; Lyulcheva-Bennett E; Hart R; Pizer B; Hayden J; Ramakrishnan R
    J Pediatr Endocrinol Metab; 2024 May; 37(5):467-471. PubMed ID: 38529810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paternal GNAS mutations lead to severe intrauterine growth retardation (IUGR) and provide evidence for a role of XLαs in fetal development.
    Richard N; Molin A; Coudray N; Rault-Guillaume P; Jüppner H; Kottler ML
    J Clin Endocrinol Metab; 2013 Sep; 98(9):E1549-56. PubMed ID: 23884777
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.